Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study | LANCET ONCOLOGY |